DrugPatentWatch Database Preview

Vincristine sulfate - Generic Drug Details

What are the generic sources for vincristine sulfate and what is the scope of vincristine sulfate patent protection?

Vincristine sulfate is the generic ingredient in six branded drugs marketed by Talon Therap, Lilly, Teva Parenteral, Bristol Myers Squibb, Abic, Abraxis Pharm, Fresenius Kabi Usa, Hospira, and Teva Pharms Usa, and is included in thirteen NDAs. There are three patents protecting this compound. Additional information is available in the individual branded drug profile pages.

There are thirteen drug master file entries for vincristine sulfate. Three suppliers are listed for this compound.

US Patents:	3
Tradenames:	6
Applicants:	9
NDAs:	13
Drug Master File Entries:	13
Suppliers / Packagers:	3
Bulk Api Vendors:	29
Clinical Trials:	122
Patent Applications:	7,480
Formulation / Manufacturing:	see details
Patent Litigation and PTAB cases:	See patent lawsuits and PTAB cases for vincristine sulfate
DailyMed Link:	vincristine sulfate at DailyMed

Ingredient-type	Vinca Alkaloids
Drug Class	Vinca Alkaloid

Antineoplastic Agents, Phytogenic
Tubulin Modulators

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Talon Therap	MARQIBO KIT	vincristine sulfate	INJECTABLE, LIPOSOMAL;INTRAVENOUS	202497-001	Aug 9, 2012		RX	Yes	Yes	➤ Sign Up	➤ Sign Up	Y			➤ Sign Up
Talon Therap	MARQIBO KIT	vincristine sulfate	INJECTABLE, LIPOSOMAL;INTRAVENOUS	202497-001	Aug 9, 2012		RX	Yes	Yes	➤ Sign Up	➤ Sign Up				➤ Sign Up
Hospira	VINCRISTINE SULFATE PFS	vincristine sulfate	INJECTABLE;INJECTION	071484-001	Apr 19, 1988	AP	RX	No	Yes	➤ Sign Up	➤ Sign Up				➤ Sign Up
Lilly	ONCOVIN	vincristine sulfate	INJECTABLE;INJECTION	014103-003	Mar 7, 1984		DISCN	No	No	➤ Sign Up	➤ Sign Up				➤ Sign Up
Hospira	VINCRISTINE SULFATE	vincristine sulfate	INJECTABLE;INJECTION	071560-001	Apr 11, 1988		DISCN	No	No	➤ Sign Up	➤ Sign Up				➤ Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Lilly	ONCOVIN	vincristine sulfate	INJECTABLE;INJECTION	014103-003	Mar 7, 1984	➤ Sign Up	➤ Sign Up
Talon Therap	MARQIBO KIT	vincristine sulfate	INJECTABLE, LIPOSOMAL;INTRAVENOUS	202497-001	Aug 9, 2012	➤ Sign Up	➤ Sign Up
Talon Therap	MARQIBO KIT	vincristine sulfate	INJECTABLE, LIPOSOMAL;INTRAVENOUS	202497-001	Aug 9, 2012	➤ Sign Up	➤ Sign Up
Talon Therap	MARQIBO KIT	vincristine sulfate	INJECTABLE, LIPOSOMAL;INTRAVENOUS	202497-001	Aug 9, 2012	➤ Sign Up	➤ Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration